Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03486405 · ClinicalTrials.gov registry record · NA
A Randomized Control Trial: Returning to Run After Injury
A NA study, sponsored by Keller Army Community Hospital.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03486405: Completed NA study, sponsored by Keller Army Community Hospital.
NCT03486405 is a NA study that has completed, run by Keller Army Community Hospital. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03486405, a NA study, has completed, sponsored by Keller Army Community Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effectiveness of telehealth via video feedback to transition rear foot strike runners to non-heel strike runner following a lower extremity injury. Telehealth re-education gait training is much cheaper than in-clinic retraining sessions with a medical provider and could be much more widely used by both consumers and researchers as a training aid, a way to help alter running form, prevent running injuries and be used as a tool for use in the rehabilitation of running related injuries.
Primary Outcome
Analyzed through slow motion camera on an instrumented treadmill.
Interventions
- OTHER Control group
- OTHER Intervention group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2019-05-15 |
| Phase | NA |
What the finished NCT03486405 record still lists
NCT03486405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Control group is the first listed.
NCT03486405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03486405 about?
NCT03486405 is a clinical study titled "A Randomized Control Trial: Returning to Run After Injury". The purpose of this study is to examine the effectiveness of telehealth via video feedback to transition rear foot strike runners to non-heel strike runner following a lower extremity injury. Telehealth re-education gait training is much cheaper than in-clinic retraining sessions with a medical prov...
What is the current status of trial NCT03486405?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-10-04. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT03486405?
The interventions under investigation include: Control group (OTHER), Intervention group (OTHER).
Who is sponsoring clinical trial NCT03486405?
This trial is sponsored by Keller Army Community Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03486405's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI